Generic medicines are essential in healthcare, offering affordable alternatives to brand-name drugs. They provide the same benefits as branded medica ...
We at Globela have strengthened our organization to create high quality and affordable health care solutions and reach the most under-served sections of the society, across the Globe.
Globela Pharma is the leading pharmaceutical manufacturer with an expertise in R&D and a passion for innovation aligned with the industry’s gold standards to ensure high quality products made accessible and affordable.
Globela Pharma is the leading pharmaceutical manufacturer with an expertise in R&D and a passion for innovation aligned with the industry’s gold standards to ensure high quality products made accessible and affordable.
Globela Pharma is the leading pharmaceutical manufacturer with an expertise in R&D and a passion for innovation aligned with the industry’s gold standards to ensure high quality products made accessible and affordable.
Globela has been forefront of innovation for nearly Seventeen years. From humble beginnings in 2006 as small pharmaceutical company, Globela’s current portfolio of vertically aligned businesses is today focused on various therapeutic areas of Gastroenterology, Cardiovascular, Diabetology, Oncology, Pain management, Nephrology and more.
A EU GMP, WHO GMP, ISO Certified, MNC Accredited company, Globela also boasts of advanced research and development capability, at high quality standards complying manufacture facilities at wide range of Finished Dosage Formulations, DC Granules and Pellets (semi-finished), APIs and Intermediates.
We as committed to achieving greater value for patients innovation and continuous improvement across our core businesses.
Leading the pharmaceutical revolution in 50+ nations across the globe with highly researched, affordable and accessible healthcare products.
Generic medicines are essential in healthcare, offering affordable alternatives to brand-name drugs. They provide the same benefits as branded medica ...
In lower and middle-income countries (LMICs), healthcare access is a significant challenge. The WHO reports that nearly two billion people globally s ...
In life cycle for drug, at discovery till launch, are series crucial steps are involved in order to comply with regulatory requirements has per respective local regulatory authority...
Health is indeed the greatest wealth one can have. Being vigilant towards the health of yourself and your loved ones is a top priority...
WhatsApp us
Enter your name and email to download PDF.
Enter your name and email to download PDF.
Enter your name and email to download PDF.